Nanobiotix S.A. - Sponsored ADR

NBTX Healthcare Biotechnology

21.30 0.93 −4.18%
Market cap
$1.1B
P/E
0.0×
Fwd P/E
—
Dividend yield
—
F-score
n/a
Altman Z
3.40
Beneish M
n/a
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Cash and Short Term Investments
59.68 53.82 81.48 43.61 99.29 136.11 39.31 41.61 56.88 22.17
Receivables
2.42 3.22 0.98 0.11 4.41 0.07 0.01 6.15 5.90 5.29
Other current assets
8.90 9.47 12.07 11.45 10.81 6.89 12.34 1.26 1.20 0.85
Total current assets
71.00 66.51 94.53 55.16 110.10 143.07 51.66 49.02 63.99 28.31
Property, Plant, Equpment (Net)
5.17 5.99 6.77 7.50 9.68 9.43 10.51 3.31 3.60 2.56
Long-Term Investments
0.49 0.44 0.32 0.31 0.61 0.58 0.59 — 0.60 0.53
Goodwill and Intangible Assets (Total)
0.01 0.01 0.01 0.00 0.00 0.02 0.18 0.12 0.16 0.00
Long-term assets (Other)
— — — — — — — 0.44 0.55 0.35
Total non-current assets
5.67 6.44 7.10 7.81 10.30 10.03 11.29 — — —
Total Assets
76.66 72.95 101.62 62.97 120.40 153.10 62.95 52.90 — 31.75
Accounts Payable
10.32 21.68 19.74 10.14 7.67 8.12 8.70 7.48 6.20 4.60
Current Part of Debt
— — — — — — — 0.57 0.93 1.14
Current Revenue (Deferred)
0.05 0.07 0.14 0.06 19.54 — — — — —
Other current liabilities
54.69 42.03 34.10 29.77 16.38 13.63 7.37 5.07 3.87 2.76
Total current liabilities
65.06 63.77 53.98 39.97 43.59 21.75 16.07 13.33 11.27 8.68
Long Term Debt (Total)
— — — — — — — 23.01 4.77 4.82
Non-current Liabilities (Other)
107.18 80.28 49.64 51.50 45.12 50.86 49.02 0.38 0.28 0.18
Total non-current liabilities
107.18 80.28 49.64 51.50 45.12 50.86 49.02 — — —
Total liabilities
172.25 144.05 103.62 91.47 88.71 72.61 65.09 36.73 16.32 13.69
Additional Paid In Capital
355.71 338.42 338.48 269.47 302.60 292.13 171.52 — — —
Common Stock (Net)
1.64 1.54 1.53 1.10 1.24 1.18 0.75 0.68 0.71 0.50
Retained Earnings
(27.11) (73.73) (42.97) (60.10) (55.61) (38.37) (57.02) — — (23.03)
Treasury Stock
0.26 0.25 0.25 0.24 0.24 0.22 0.19 — — —
Shareholders Equity (Other)
(426.35) (337.85) (299.59) (239.46) (217.05) (174.85) (117.68) — — —
Common Equity (Total)
(95.58) (71.10) (2.00) (28.49) 31.70 80.50 (2.14) 16.17 52.59 18.06
Shareholders Equity (Total)
(95.58) (71.10) (1.99) (28.49) 31.70 80.50 (2.14) 16.17 52.59 18.06
Shareholders Equity and Liabilities (Total)
76.66 72.95 101.62 62.97 120.40 153.10 62.95 — — —
Shares (Common)
48.41 47.43 47.13 34.88 34.83 34.43 22.42 — — —
Shareholders Equity (Tangible)
(95.59) (71.11) (2.00) (28.50) 31.69 80.47 (2.32) — — —
Net Debt
(59.68) (53.82) (81.48) (43.61) (99.29) (136.11) (39.31) (18.03) (51.18) (16.20)
Total Debt
— — — 56.56 52.30 60.47 50.03 23.59 5.70 5.97

Fold the line items

In millions of $ except per-share values · columns are period end dates · fundamentals updated 28 Sep 2026